Novo Nordisk Expands Aspect Biosystems Partnership for Diabetes Cell Therapy
Novo Nordisk (NYSE: NVO) and Canadian biotechnology firm Aspect Biosystems announced a new phase in their...
Deals
Sisram Medical Partners with Fosun Pharma Subsidiary on Local Production Base
Sisram Medical Ltd (HKG: 1696), an Israel‑based beauty and wellness group and part of Fosun...
BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto‑Injector
Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration...
Syngene Extends BMS Partnership to 2035, Expanding CRDMO Services
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the extension of...
PrimeGenX Therapeutics Files for Hong Kong IPO with JAK‑STAT Pipeline
PrimeGenX Therapeutics Co., Ltd., a Beijing‑based immune‑inflammatory disease specialist founded in 2016, has filed for...
Bio‑Sincerity Pharma‑Tech Secures Greater China Priority Rights for Delim’s Semaglutide and Tirzepatide Portfolio
Hangzhou Bio‑Sincerity Pharma‑Tech Co., Ltd. (SHE: 301096) announced a strategic cooperation agreement with Delim Cosmetics...
TaiGen and Joincare Partner on TG‑4318 DPP1 Inhibitor for Bronchiectasis in Greater China
TaiGen Biotechnology and Joincare Pharmaceutical Group (SHA: 600380) announced a licensing agreement for the collaborative...
China Isotope & Radiation Corporation Signs Commercial Deal for Pluvicto, China’s First PSMA Radioligand Therapy
China Isotope & Radiation Corporation (HKG: 1763) announced it has officially entered into a commercial...
Matwings Technology Partners with Leading US Biotech on AIACCLBIO Platform for Biopharmaceutical Pipeline
Matwings Technology, a pioneer in AI‑driven protein engineering, announced a strategic biopharmaceutical pipeline collaboration with...
AmCellGene Licenses Mesenchymal Stem Cell Therapy for ACLF to Advanced Regeneration in First Chinese Stem Cell Outbound Deal
Tianjin AmCellGene Co., Ltd. has granted Hong Kong‑based Advanced Regeneration exclusive regional rights to commercialize...
Huadong Medicine Secures Exclusive China Commercialization Rights for Linaprazan Glurate P‑CAB from Sinorda
Huadong Medicine Co., Ltd. (SHE: 000963), a leading China‑based pharmaceutical group, announced an exclusive commercialization...
Novavax Licenses Matrix-M Adjuvant to Pfizer in $530M Deal
Novavax, Inc. (NASDAQ: NVAX) entered into a license agreement with Pfizer Inc. for non‑exclusive rights to...
BioRay Pharmaceutical Files HKEX IPO, Backed by First‑in‑Class Autoimmune and Oncology Pipeline
Zhejiang-based BioRay Pharmaceutical Co., Ltd announced an initial public offering (IPO) filing to the Hong...
BMS Partners with Microsoft on AI‑Powered NSCLC Detection Platform
Bristol‑Myers Squibb (BMS, NYSE: BMY) announced a collaboration with Microsoft to accelerate early detection of non‑small...
Bayer Partners with Vanderbilt in 5‑Year Deal to Accelerate Cardio‑Renal Drug Discovery
Bayer AG (ETR: BAYN) and Vanderbilt University Medical Center (VUMC) announced a strategic five‑year collaboration to...
Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform
Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to...
GSK Acquires RAPT Therapeutics for $2.2 Billion, Adding Ozureprubart for Food Allergy Protection
GlaxoSmithKline plc (GSK, NYSE: GSK) announced a definitive agreement to acquire RAPT Therapeutics (NASDAQ: RAPT) for USD 58.00...
Alteogen Licenses ALT‑B4 Hyaluronidase to Tesaro for $285M Subcutaneous Dostarlimab Deal
Alteogen Inc. (KOSDAQ: 196170) announced an exclusive license agreement with Tesaro, a GSK subsidiary, granting worldwide...
Eyebright Medical to Acquire Control of Delta Medical in $143 M Sports‑Medicine Deal
Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of...
Insilico Licenses NLRP3 Inhibitor ISM8969 to Hengtai in $64M CNS Drug Deal
Insilico Medicine (HKG: 3696), a generative AI‑driven biotech, announced a partnership with Shenzhen Hengtai Biotechnology...